PATENT CLAIM ANALYSIS

Application Number: 15902175
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "134100"]

Abstract:
The present invention relates to an isolated fusion protein comprising an extracellular CD95 domain or a functional fragment thereof and an Fc domain or functional fragment thereof, formulations providing such fusion protein in a stable form as well as a method for producing such a fusion protein.

Claim (Index 6):
The method according to  claim 5 , wherein the polypeptide comprises a mature peptide starts with lysine, threonine, aspartic acid or glutamine.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15239127', '14415871', '13403826', '12439486', '12999607']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6906630228969648
- 35 USC 102 Novelty (BERT): 0.4760096839629224
- Combined Prediction Score: 0.6691976890035606
- Mean Citation Score: 180.200008
- Max Citation Score: 225.79568
- Similarity Product: 215.47907536787991

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test